A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the Unit Read More >>

The Bombay High Court on Thursday asked troubled drugmaker Wockhardt and its promoters to cla Read More >>

Abbott Laboratories (ABT)

Expected next earnings release:

Announcement date: 4/21/2010 - Before Market

Earnings Quarter: Q1

Announc
          
            Read More
            >>
          
        

Abbott Laboratories, a US-based manufacturer and seller of healthcare products, has signed an exclusive worldwide licensing agreemen Read More >>

Health Discovery Corporation (OTCBB: HDVY) announced today that the Company has entered into an exclusive agreement with the Pancreas, Read More >>

Abbott Laboratories (ABT)

Expected next earnings release:

Announcement date: 4/21/2010 - Before Market

Earnings Quarter: Q1

Announc
          
            Read More
            >>
          
        

Research and Markets (http://www.researchandmarkets.com/research/a0a69f/abbott_laboratorie) has announced the addition of the "Abbott Laboratories Read More >>

Absolute(R) Software Corporation ("Absolute" or the "Company") (TSX: ABT), the leading provider of firmware-based, patented, computer theft rec Read More >>

As he begins a new decade as chief executive of Abbott Laboratories, Miles White hinted he may not be done whee Read More >>

Texas' largest university system deploys Absolute Manage on all their Mac computers

Absolute(R) Software Corporation ("Absolute" or t Read More >>

Abbott Laboratories, a US-based manufacturer and seller of healthcare products, has signed an exclusive worldwide licensing agreemen Read More >>

Absolute Software Corporation (TSX:ABT) has introduced Absolute Manage, the rebranded version of its recently-acquired cross-platform IT asset manage Read More >>

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

Absolute Manage enables organizations to easily manage PC, Mac and iPhone devices from a single interface

Absolute(R) Software Corpor Read More >>

Absolute(R) Software (TSX: ABT), the leading provider of firmware-based, patented computer theft recovery, data protection and secure IT asse Read More >>

Abbott (NYSE: ABT) announced today an exclusive worldwide licensing agreement with Pierre Fabre SA to develop and com Read More >>

Absolute Software (ABT)

Expected next earnings release:

Announcement date: 2/1/2010 - After Market

Earnings Quarter: Q2

Announcemen
          
            Read More
            >>
          
        

Absolute Software (ABT)

Expected next earnings release:

Announcement date: 2/1/2010 - After Market

Earnings Quarter: Q2

Announcemen
          
            Read More
            >>
          
        

Abbott Laboratories (ABT)

Expected next earnings release:

Announcement date: 4/15/2010 - Before Market

Earnings Quarter: Q1

Announc
          
            Read More
            >>
          
        

Tekmira Pharmaceuticals Corporation (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary deliv Read More >>

Tekmira Pharmaceuticals Corporation (TSX: TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary del Read More >>

Absolute Software co-hosts free webinar on how one K-12 school district simplified IT asset management and theft deterrence for their 1:1 co Read More >>

Abbott Laboratories this morning reported flat fourth-quarter profits amid the global economic downturn and inc Read More >>

Abbott Laboratories (ABT)

Expected next earnings release:

Announcement date: 1/27/2010 - Before Market

Earnings Quarter: Q4

Announc
          
            Read More
            >>
          
        

Kevin Matras goes over a screen to find top stocks with strong dividends. Stocks in this week's article include Abbott Labs (NYSE: ABT), Read More >>

Abbott Laboratories this morning reported flat fourth-quarter earnings amid the global economic downturn and in Read More >>

Stocks moved sideways Tuesday during a day of base building with buyers idle due to wariness over political and regulatory issues, discounting solid earnings Read More >>

Abbott Laboratories (NYSE: ABT) said it expects 2010 earnings of $4.20 to $4.25 per share. The current consensus earnings estimate i Read More >>

Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2009.

Diluted earnings per share, excl Read More >>

(Comment on this article at http://www.financialwire.net/2010/01/27/conference-calls-today-9-a-m-est-6/)

January 27, 2010 (FinancialWire) (Invest Read More >>

Abbott Laboratories (ABT)

Expected next earnings release:

Announcement date: 1/27/2010 - Before Market

Earnings Quarter: Q4

Announc
          
            Read More
            >>
          
        

Seven Summits Research issues PriceWatch Alerts for PEP, CHK, STX, ABT, and HRS.

Seven Summits Strategic Investments' PriceWatch Alerts are Read More >>

Abbott Laboratories (ABT)

Expected next earnings release:

Announcement date: 1/27/2010 - Before Market

Earnings Quarter: Q4

Announc
          
            Read More
            >>
          
        

The European Commission said on Friday that it has extended its investigation into the proposed acquisition of Solvay Pharmaceuticals by US health care Read More >>

An assay to aid in the early detection of HIV infection may soon be available in the United States. Abbott (NYSE: ABT) announced today i Read More >>

25 January 2010 - S&P has reiterated its "buy" rating on Danish pharmaceutical companies Genmab (CPH: GEN) and Neurosearch A/S (CPH: NEUR).

L Read More >>

Following a regulatory recommendation, Abbott Laboratories appears to have suspended sales of its controversial obesity drug Reductil in Europe. Meanwhile, Read More >>

A patent on a University of Iowa professor's biomedical discovery has yielded a second multimilliondolla Read More >>

U.S. government officials said Thursday the manufacturer of the weight-loss drug sibutramine, or Meridia, will issue a tougher warning about the drug. Read More >>

Absolute Software (ABT)

Expected next earnings release:

Announcement date: 2/1/2010 - After Market

Earnings Quarter: Q2

Announcemen
          
            Read More
            >>
          
        

Today the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) voted to recommend the Read More >>

Attorney Advertising -- Keller Rohrback L.L.P. (www.krclassaction.com) announces that it is investigating possible claims against Nestle USA, Inc Read More >>

Wall Street News Alert's "stocks to watch" this morning are: Spine Pain Management, Inc. (OTCBB: SPIN), Abbott (NYSE: ABT), Amylin Pharmaceutic Read More >>

Absolute Software (ABT)

Expected next earnings release:

Announcement date: 2/1/2010 - After Market

Earnings Quarter: Q2

Announcemen
          
            Read More
            >>